Barrow Hanley Mewhinney & Strauss LLC Sells 3,386 Shares of The Procter & Gamble Company (NYSE:PG)

Barrow Hanley Mewhinney & Strauss LLC lowered its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 115,834 shares of the company's stock after selling 3,386 shares during the period. Barrow Hanley Mewhinney & Strauss LLC's holdings in Procter & Gamble were worth $19,420,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Cladis Investment Advisory LLC increased its holdings in Procter & Gamble by 5.2% during the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock worth $806,000 after purchasing an additional 236 shares in the last quarter. FAS Wealth Partners Inc. boosted its position in shares of Procter & Gamble by 2.0% during the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company's stock valued at $4,642,000 after buying an additional 549 shares during the last quarter. Berkshire Asset Management LLC PA grew its holdings in Procter & Gamble by 0.9% during the fourth quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company's stock worth $38,833,000 after buying an additional 2,179 shares in the last quarter. Strategic Advisors LLC raised its position in Procter & Gamble by 3.4% in the 4th quarter. Strategic Advisors LLC now owns 55,912 shares of the company's stock valued at $9,374,000 after buying an additional 1,818 shares during the last quarter. Finally, Richard C. Young & CO. LTD. lifted its stake in Procter & Gamble by 2.1% during the 4th quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company's stock valued at $20,764,000 after acquiring an additional 2,568 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Transactions at Procter & Gamble

In related news, CEO Gary A. Coombe sold 35,000 shares of the business's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares in the company, valued at $3,829,817.68. The trade was a 61.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now owns 51,965 shares in the company, valued at $8,386,111.70. The trade was a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 46,520 shares of company stock valued at $7,909,388. 0.18% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

PG has been the topic of a number of recent analyst reports. Raymond James dropped their price target on shares of Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research report on Friday, April 25th. Bank of America cut their target price on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Piper Sandler boosted their price objective on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research report on Monday, May 5th. Finally, Citigroup decreased their target price on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Eight analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $178.52.

Procter & Gamble Price Performance

Shares of PG traded down $0.43 during midday trading on Wednesday, hitting $167.33. 5,364,796 shares of the company traded hands, compared to its average volume of 7,284,173. The stock has a 50-day moving average of $164.14 and a 200-day moving average of $167.35. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The Procter & Gamble Company has a one year low of $156.58 and a one year high of $180.43. The firm has a market cap of $392.31 billion, a P/E ratio of 26.64, a PEG ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The firm had revenue of $19.78 billion during the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business's quarterly revenue was down 2.1% compared to the same quarter last year. During the same period last year, the firm earned $1.52 EPS. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Monday, April 21st were issued a $1.0568 dividend. The ex-dividend date was Monday, April 21st. This represents a $4.23 annualized dividend and a dividend yield of 2.53%. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's dividend payout ratio (DPR) is presently 66.98%.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.